Latest Updates

Articles posted in the "Latest Updates" are compiled and published into a bulletin quarterly.

Previously published articles are available within the Noridian Bulletins webpage. Exclusions to this include time-sensitive announcements such as: Noridian and CMS educational Events, Ask-the-Contractor Teleconferences, and claims processing downtime.

The information included in the Latest Updates is also available by subscribing to the Noridian email list. Medicare news, regulations, workshop notices, and other related notifications will be delivered to you each week. Register Now!

Articles Source Posted
CERT Awareness Month: Steps to Take if You Get a Cert Documentation Request Jul 14, 2025
Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors (A58973) - R9 - Effective July 1, 2025 Jul 10, 2025
Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers (A58454) - R11 - Effective July 1, 2025 Jul 10, 2025
MolDX: Molecular Testing for Solid Organ Allograft Rejection (L38629) - R1 - Effective July 10, 2025 Jul 10, 2025
MLN Connects - July 10, 2025 Jul 10, 2025
Alert: Medicare Fraud Scheme Involving Phishing Fax Requests Jul 07, 2025
CERT Awareness Month: 2025 CERT Documentation Deadline Jul 07, 2025
Billing and Coding Investigational Device Exemptions (IDE) - IDE Documentation Requirements for Studies with an FDA Approval dated January 01, 2015, or later (A54919) - R8 - Effective October 1, 2015 Jul 03, 2025
MLN Connects - July 3, 2025 Jul 03, 2025
2025 Q3 MolDX CPT/HCPCS Billing and Coding Article Updates - Effective July 1, 2025 Jul 03, 2025
Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (A58720) - R26 - Effective July 1, 2025 Jul 03, 2025
Billing and Coding: MolDX: Pharmacogenomics Testing (A57384) - R16 - Effective July 1, 2025 Jul 03, 2025
MolDX: Breast Cancer Index (BCI) Gene Expression Test (L37822) - R5 - Effective July 3, 2025 Jul 03, 2025
MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer (L39005) - R2 - Effective July 3, 2025 Jul 03, 2025
MolDX: Pharmacogenomics Testing (L38335) - R2 - Effective July 3, 2025 Jul 03, 2025
MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells (L38643) - R2 - Effective July 3, 2025 Jul 03, 2025
MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer (L38327) - R3 - Effective July 3, 2025 Jul 03, 2025
MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer (L38647) - R2 - Effective July 3, 2025 Jul 03, 2025
MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease (L38339) - R3 - Effective July 3, 2025 Jul 03, 2025
MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing (L39001) - R4 - Effective July 3, 2025 Jul 03, 2025
MolDX Local Coverage Determinations (LCDs) Finalized - Effective August 17, 2025 Jul 03, 2025
Billing and Coding: Implantable Infusion Pumps for Chronic Pain (A55239) - R21 - Effective July 1, 2025 Jul 03, 2025
DMEPOS Fee Schedules and Labor Payment - 3rd quarter 2025 update Jul 02, 2025
Recovery Audit Contract Announcement Jul 02, 2025
How to Register Your Molecular Diagnostics (MolDX) Test - On-Demand Tutorials Available Jun 30, 2025
DMEPOS Fee Schedule: July 2025 Quarterly Update CR14088 Jun 26, 2025
Clinicians - Are You Ordering Urological Supplies for Your Patients Jun 26, 2025
MLN Connects - June 26, 2025 Jun 26, 2025
Self-Administered Drug Exclusion List (A53032) - R42 - Effective July 1, 2025 Jun 26, 2025
2025 CPT/HCPCS Billing and Coding Article Updates - Effective July 1, 2025 Jun 26, 2025